Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance

By sjmartinez • November 9, 2023

Karpouzas GA, Szekanecz Z, Baecklund E, Mikuls TR, Bhatt DL, Wang C, Sawyerr GA, Chen Y, Menon S, Connell CA, Ytterberg SR, Mortezavi M. Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance. Ther Adv Musculoskelet Dis. 2023 Nov 6;15:1759720X231201047. doi: 10.1177/1759720X231201047. PMID: 37942277; PMCID: PMC10629315.

Tags: autoinflammatory conditions, DMARDs, Inflammation, outcome measures, Publications, Rheumatoid arthritis, Rheumatology

Primary Care Practice Productivity and Efficiency: Qualitative Evaluation of a Novel Clinic-Based Measure

McCleskey SG, Khodyakov D, Nelson KM, Curtis I, Newberry SJ, Tran LD, Fihn SD, Wagner TH, Rubenstein LV. Primary Care Practice Productivity and Efficiency: Qualitative[...]

Impact of a stigma-disrupting addiction medicine core curriculum on internal medicine resident attitudes and preparedness: results from a pilot study

Lawrence D, Marshall KF. Impact of a stigma-disrupting addiction medicine core curriculum on internal medicine resident attitudes and preparedness: results from a pilot study. BMC[...]

Decade Growing in Plain Sight: Detection of an Invasive Melanoma Within a Long-Standing Pigmented Lesion

Freeman M, Gates G, Ahronowitz I. Decade Growing in Plain Sight: Detection of an Invasive Melanoma Within a Long-Standing Pigmented Lesion. Cureus. 2026 Oct 10;18(10):e117734.[...]